Loading...

Major Indexes

Financial Summary


Mesa Laboratories Inc.

Mesa Laboratories Inc. (MLAB)

$264.25
4.83 (+1.86%)
Buy
A+
Market Info
Financial Info
Financial Modelling
Symbol MLAB
Price 264.25$
Beta 0.21
Volume Avrg. 0.04M
Market Cap 1.15B
Shares (2019) 4,033.00K
Last Div 0.64
Dividend Yield 0.23%
DCF Unlevered -1,992.30 Strong Sell
DCF Levered -
ROE 6.72% Neutral
ROA 4.77% Neutral
Operating Margin 9.48% Neutral
Debt / Equity 40.84% Neutral
P/E 123.23 Strong Buy
P/B 8.29 Strong Buy

Income Statement

Download MLAB income statement Download MLAB income statement Download MLAB income statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Earnings Per Share Basic 1.491.912.412.522.612.723.103.04-0.791.95
Net Profit Margin 0.220.180.200.180.170.130.130.12-0.030.07
Earnings Per Share Diluted 1.451.862.292.352.492.632.972.91-0.791.86
Revenue 21.9334.2339.6246.4452.7271.3384.6693.6796.18103.14
Weighted Average Shares Outstanding 3.203.253.293.363.443.523.603.683.773.84
Gross Profit 13.1919.5723.5128.8631.6943.3951.4153.2454.6260.92
Weighted Average Shares Outstanding (Diluted) 3.193.233.463.593.613.653.763.843.774.03
Sales, General and Administrative Expense 5.168.269.329.1211.4617.0623.6222.8126.2531.30
Dividend per Share 0.000.000.000.000.000.000.000.000.000.00
Operating Income 7.379.8612.4813.1011.7915.8616.3216.312.189.78
Gross Margin 0.600.570.590.620.600.610.610.570.570.59
Earnings before Tax 7.409.7512.3312.9813.1015.3515.5514.300.308.62
EBITDA Margin 0.370.340.370.360.300.300.280.270.120.19
Net Income 4.776.187.928.459.009.5811.1711.18-2.967.48
EBIT Margin 0.340.280.310.280.220.220.190.170.020.09
Net Income - Discounted ops ----------
Profit Margin 0.220.180.200.180.170.130.130.12-0.030.07
Preferred Dividends ----------
Free Cash Flow margin 0.000.000.000.000.000.000.000.000.000.00
R&D Expenses 0.671.441.362.012.323.293.974.163.543.51
Interest Expense ----------
Earnings Before Tax Margin 0.340.280.310.280.250.220.180.150.000.08
Consolidated Income 4.776.187.928.459.009.5811.1711.18-2.967.48
EBIT 7.409.7512.4813.1011.7915.8616.3216.312.189.78
EBITDA 8.1911.6014.6916.5415.6321.5223.5025.0511.7619.21
Income Tax Expense 2.633.574.414.534.105.764.393.113.261.14
Operating Expenses 5.839.7011.0315.7619.9027.5335.0936.9352.4451.13
Cost of Revenue 8.7314.6616.1117.5721.0427.9433.2540.4341.5642.22
Net Income Com 4.776.187.928.459.009.5811.1711.18-2.967.48
Net Income - Non-Controlling int ----------

Balance Sheet Statement

Download MLAB balance shet statement Download MLAB balance sheet statement Download MLAB balance sheet statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Total current liabilities 1.949.934.264.6610.2114.6623.9716.5717.2923.66
Other Liabilities 1.463.61-2.141.620.814.430.12--
Long-term debt -1.50-4.0016.5023.2542.2553.6744.6320.61
Cash and cash equivalents 10.473.557.194.015.582.035.705.825.4710.19
Total debt -6.50-4.0016.5026.2545.2554.8046.2622.74
Cash and short-term investments 10.473.557.194.015.582.035.705.825.4710.19
Deferred revenue ----1.891.313.034.123.923.96
Inventories 4.825.714.445.587.7712.4214.0213.879.236.77
Tax Liabilities 0.633.611.051.15-1.212.240.511.011.36
Goodwill and Intangible Assets 8.9325.9324.2739.0663.2878.10106.93109.95108.3999.60
Deposit Liabilities ----------
Tax assets 0.380.650.710.851.881.691.221.970.272.55
Total non-current liabilities 0.504.212.526.3621.3628.3747.6757.2347.4521.80
Total current assets 20.4717.3219.1619.4526.5729.6237.1935.7831.9933.62
Total liabilities 2.4414.146.7813.1733.2043.8476.0773.9164.7445.46
Payables 0.481.320.571.012.022.502.822.172.382.90
Other comprehensive income ----------
Short-term investments ----------
Retained earnings (deficit) 26.3131.3537.6142.1848.5655.9664.8373.6668.2873.30
Property, Plant & Equipment Net 4.247.317.277.417.689.6016.6326.0023.5922.23
Total non-current assets 13.1633.2431.5446.4670.9687.70123.56135.95132.11123.14
Other Assets 0.761.04--------
Net Debt -10.472.95-7.19-0.0110.9324.2239.5548.9840.7912.55
Investments ----------
Total shareholders equity 31.2036.4243.9152.7564.3373.4884.6897.8299.36111.31
Total assets 33.6450.5650.7065.9297.53117.32160.75171.73164.10156.77
Long-term investments ----------
Receivables 4.437.026.498.479.2812.1415.3114.3214.3012.52
Short-term debt -5.00---3.003.001.131.632.13

Cash Flow Statement

Download MLAB cash flow statement Download MLAB cash flow statement Download MLAB cash flow statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Insurance (repayment) of debt ----------
Net Cash/Marketcap 0.00-0.00--------
Insurance (buybacks) of shares ----------
Depreciation & Amortization 0.791.842.213.433.845.667.178.749.589.43
Dividend payments -1.34-1.49-1.65-1.81-1.99-2.18-2.30-2.35-2.41-2.46
Operating Cash Flow 5.988.8712.4911.4012.3710.8216.907.7524.8130.55
Acquisitions and disposals -2.58-17.97-0.74-16.66-22.76-20.54----
Free Cash Flow 5.396.2212.4911.4012.3710.8216.907.7524.8130.55
Net cash flow / Change in cash 1.36-6.927.194.015.582.033.660.13-0.354.72
Effect of forex changes on cash ------0.06-0.020.070.14-0.29
Financing Cash Flow -1.464.83-7.422.9812.339.0718.6210.71-8.12-21.67
Investment purchases and sales ---0.09-0.10-0.02-----
Capital Expenditure -0.59-2.65--------
Stock-based compensation 0.280.380.461.110.840.991.331.411.674.21
Investing Cash Flow ----------

Retained Earning Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Retained Earnings (Previous Year) -263138424956657468
Net Income 56889101111-37
Stock Dividends 230-0-2-1-----
Dividend Paid -1-1-2-2-2-2-2-2-2-2
Retained Earnings 26313842495665746873

PPE Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Gross PPE -4777810172624
Annual Depreciation 56-000279-2-1
Capital Expenditure -1-3--------
Net PPE 477781017262422

Intangible and Goodwill Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Intangible and Goodwill (Previous Year) -92624396378107110108
New Purchases ---0-0-0-----
Intangible and Goodwill 92624396378107110108100

About


Gary Owens
Technology
Computer Hardware
Nasdaq Global Select

Mesa Laboratories Inc designs, manufactures and markets quality control instruments and disposable products and also manufactures and markets biological indicators and distributes chemical indicators.